Skip to main content
Fig. 3 | World Journal of Surgical Oncology

Fig. 3

From: Loss of NPM2 expression is a potential immunohistochemical marker for malignant peritoneal mesothelioma: a single-center study of 92 cases

Fig. 3

Survival analysis. A Overall survival. B NPM2 protein expression. C Karnofsky performance status score. D Increased preoperative tumor markers (any one of carcinoembryonic antigen, carbohydrate antigen (CA) 19-9, CA 125, and alpha-fetoprotein was increased). E Ascites. F Red blood cell infusion. G Ki-67. H Vascular tumor emboli. I Serious adverse events

Back to article page